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CASE REPORT
Increased 18F-FDG-PET Uptake in Granulomatosis with 
Polyangiitis: Case Report and Review of the Literature
 Rama El-Yafawi, MD,1 Patricia Cantlin, DO,2 Thomas E. Van der Kloot, MD1 
¹Departments of Pulmonary/Critical Care Medicine, Maine Medical Center, Portland, ME , 2Department of Nephrology, 
Maine Medical Center, Portland, ME
Granulomatosis with polyangiitis (GPA) is the most common of the antineutrophil cytoplasmic autoantibody (ANCA)-
associated vasculitides. It frequently involves 
the kidneys and the upper and lower respiratory 
tracts.1 Up to 22% of patients have disease limited 
to the respiratory tract,2–4 which presents as 
diffuse alveolar hemorrhage (DAH) in 5–45% of 
cases.1, 5 Tracheobronchial/endobronchial disease 
is not uncommon, occurring in 10–15% of cases.2 
Hilar adenopathy and mediastinal masses are 
rare in patients with GPA, as a retrospective study 
of 302 patients reported a frequency of 2%.6 We 
describe an unusual case of GPA presenting with 
a right lower lobe (RLL) mass and hilar/mediastinal 
adenopathy.
CASE PRESENTATION
A 70-year-old woman with a smoking history 
presented with right shoulder pain and pleuritic chest 
pain. She denied cough, dyspnea, hemoptysis, 
and constitutional symptoms. Vital signs and 
physical exam were unremarkable. Laboratory 
data (including urinalysis and renal function tests) 
were normal. She reported recent air travel, raising 
concern for pulmonary embolism.
Chest computerized tomography (CT) showed 
a RLL mass of 5 cm x 4 cm (Figure 1). Also, 
18F-fluorodeoxyglucose positron emission 
tomography (FDG-PET)/CT displayed intense 
radiotracer uptake in the mass and in non-enlarged 
subcarinal, right hilar, and mediastinal lymph nodes 
(Figure 2). Given a high suspicion for malignancy, 
she underwent mediastinoscopy. Bulky adenopathy 
was identified. Biopsies showed no evidence 
of malignancy or granulomata. Flow cytometry 
was normal. CT-guided biopsy of the mass was 
performed and showed necrotic tissue with negative 
cultures. Due to continued concern for malignancy, 
video-assisted thoracic surgery was scheduled. Pre-
operative laboratory evaluation revealed a creatinine 
of 2.4 mg/dL (baseline 0.6 mg/dL), which may be 
due to the contrast used for the CT-guided biopsy. 
Four days later, creatinine was 5.7 mg/dL. Surgery 
was deferred, and she was hospitalized. Urine 
microscopy demonstrated proteinuria, hematuria 
with dysmorphic red blood cells (RBCs), and RBC 
casts, consistent with acute glomerulonephritis. 
Empiric treatment was initiated with pulse steroids. 
Unfortunately, rapid deterioration in renal function 
ensued, prompting initiation of plasmapheresis 
Figure 1: Chest CT scan showing RLL mass 
(4x5cm)
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and hemodialysis. Renal biopsy revealed severe 
crescentic glomerulonephritis with active cellular 
crescents involving 90% of the viable glomeruli 
(Figures 3 and 4). Cytoplasmic-ANCA (C-ANCA) 
was markedly elevated at 11,469 units, which 
was confirmed by enzyme-linked immunosorbent 
assay (ELISA) of antibodies to anti-proteinase 3. 
Rituximab, corticosteroids, and cyclophosphamide 
were started.
Three weeks after initiation of therapy, C-ANCA 
titer was 819 units. The patient remained dialysis-
dependent for 3 months prior to renal function 
return. Chest CT at 3 months showed that the 
mass reduced to 1.5 cm in diameter (Figure 5). 
Immunotherapy was continued. At one year, repeat 
C-ANCA titers were negative at 1.4 units and the 
RLL mass resolved (Figure 6). 
DISCUSSION
GPA is a small-vessel vasculitis with necrotizing 
granulomatous inflammation that usually affects the 
kidneys and the upper and lower respiratory tracts.7 
Approximately 85% of patients develop pulmonary 
manifestations.8 Up to half of GPA patients have 
lower airway abnormalities, including subglottic 
stenosis, ulcerating tracheobronchitis, and tracheal 
or bronchial stenosis.9–10 In 5–45% of cases, diffuse 
alveolar hemorrhage due to alveolar capillaritis is 
a prominent feature of pulmonary involvement.5 
Hilar or mediastinal lymphadenopathy is rare. Only 
ten cases of GPA have been reported with hilar or 
mediastinal adenopathy.4, 11–14
Pulmonary nodules and masses are common 
radiologic findings, and increased FDG activity has 
been reported in patients with GPA. The median for 
the maximum standardized uptake value (SUVmax) 
is usually within a range of 7.6–9.0, in contrast to our 
patient who had an SUVmax of 13.1.15–17 Despite 
its limitation in differentiating inflammatory diseases 
from malignancies, FDG-PET/CT could have a role 
in early diagnosis of GPA. In certain patients, FDG-
PET/CT can provide valuable guidance for optimal 
biopsy site, localization of organ involvement, and 
characterization of disease severity, which could 
have treatment implications.16–19 Furthermore, a 
case series reported a remarkable decrease in 
FDG uptake with treatment.19 This report indicates 
that FDG uptake correlates with disease activity in 
GPA.
This case demonstrates an unusual radiological 
presentation of GPA, with initial findings primarily 
concerning malignancy, particularly related to the 
observed increase in FDG uptake in non-enlarged 
mediastinal and hilar lymph nodes. This unusual 
presentation resulted in a delay in the diagnosis of 
GPA, which became evident only with development 
of acute kidney injury with rapidly progressive 
glomerulonephritis. Despite this delay, clinical 
response was achieved with corticosteroids, 
rituximab, cyclophosphamide, plasmapheresis, 
and hemodialysis, leading to the recovery of 
renal function, resolution of CT abnormalities, and 
normalization of C-ANCA titers.
Figure 2. PET scan showing increased FDG uptake of A) RLL mass and B) mediastinal lymph nodes
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Figure 3. Light microscopy of renal biopsy using 
hematoxylin and eosin stain (H&E stain) showing 
active cellular crescents within the glomerulus 
Figure 4. Jones basement membrane stain 
showing extensive crescentic changes and fibrosis
Figure 5. Three month follow up chest CT, showing 
reduction in mass size 
Figure 6. One year follow up chest CT, showing 
resolution of RLL mass with remnant pleural 
parenchymal scarring 
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